Cargando…
A New Murine Model of Osteoblastic/Osteolytic Lesions from Human Androgen-Resistant Prostate Cancer
BACKGROUND: Up to 80% of patients dying from prostate carcinoma have developed bone metastases that are incurable. Castration is commonly used to treat prostate cancer. Although the disease initially responds to androgen blockade strategies, it often becomes castration-resistant (CRPC for Castration...
Autores principales: | Fradet, Anaïs, Sorel, Hélène, Depalle, Baptiste, Serre, Claire Marie, Farlay, Delphine, Turtoi, Andrei, Bellahcene, Akeila, Follet, Hélène, Castronovo, Vincent, Clézardin, Philippe, Bonnelye, Edith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777927/ https://www.ncbi.nlm.nih.gov/pubmed/24069383 http://dx.doi.org/10.1371/journal.pone.0075092 |
Ejemplares similares
-
Ferlin Overview: From Membrane to Cancer Biology
por: Peulen, Olivier, et al.
Publicado: (2019) -
Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone
por: Fradet, Anais, et al.
Publicado: (2016) -
Paladin, overexpressed in colon cancer, is required for actin polymerisation and liver metastasis dissemination
por: Rademaker, Gilles, et al.
Publicado: (2022) -
Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes
por: Blomme, Arnaud, et al.
Publicado: (2016) -
Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes
por: Chiavarina, Barbara, et al.
Publicado: (2014)